Breakfast matters: new drug tested with high- and Low-Fat meals

NCT ID NCT07348133

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage study looked at how eating a high-fat or low-fat breakfast changes the way the body absorbs a new drug called HMPL-523. Eighteen healthy Chinese adults took a single 300 mg tablet under different meal conditions. The goal was to see if food affects drug levels in the blood, which helps guide future dosing instructions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

HMPL-523 acetate tablets

What this could lead to

If successful, this study will show whether HMPL-523 should be taken with or without food in future trials.

What could go wrong

This is a very early, small study in healthy people, not patients. Results may not predict real-world effects or safety in the target disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The First Affiliated Hospital of Shandong First Medical University

    Jinan, Shandong, 250014, China